NCT00040859View on ClinicalTrials.gov

Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

January 31, 2005

Study Completion Date

April 30, 2008

Conditions
Esophageal CancerGastric Cancer
Interventions
DRUG

capecitabine

DRUG

oxaliplatin

Trial Locations (6)

51101

Siouxland Hematology-Oncology Associates, LLP, Sioux City

51104

Mercy Medical Center - Sioux City, Sioux City

St. Luke's Regional Medical Center, Sioux City

57105

Avera Cancer Institute, Sioux Falls

Medical X-Ray Center, PC, Sioux Falls

57117-5039

Sanford Cancer Center at Sanford USD Medical Center, Sioux Falls

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00040859 - Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer | Biotech Hunter | Biotech Hunter